在VSMC中染色体重塑 血管重塑期间的表型切换:从机制到治疗潜力
Xiaozhu Ma1,2, Shuai Mei1,2, Qidamugai Wuyun1,2
1Division of Cardiology, Department of Internal Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1095# Jiefang Ave, Wuhan 430030, China.
染色体重塑调节血管光滑肌细胞 (VSMC) 现型切换,这是血管疾病的关键驱动因素. 针对这些表观遗传机制为血管重塑提供了潜在的治疗方法.
科学领域:
- 心血管生物学 心血管生物学
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
- 分子医学是分子医学.
背景情况:
- 血管改造是由血管光滑肌细胞 (VSMC) 现型切换驱动的,是动脉样硬化和高血压等疾病的基础.
- 在病理条件下,VSMCs从收缩型转变为增殖型,迁移型表型.
- 染色体重塑,涉及表观遗传修饰,控制基因表达对VSMC行为至关重要.
研究的目的:
- 审查染色体重塑在VSMC表型切换中的作用.
- 讨论ATP依赖的染色质重塑剂和调节VSMC表型的基因组修饰酶.
- 突出针对血管疾病的染色质重塑剂的治疗潜力.
主要方法:
- 文献综述侧重于染色体重塑和VSMC表型切换.
- 对最近在识别和表征染色体重塑分子方面的进展进行分析.
- 对临床治疗的翻译影响的讨论.
主要成果:
- 染色体重塑是VSMC表型切换的关键调节者.
- 特定的染色体重塑剂和修饰酶影响VSMC基因表达和行为.
- 表观遗传修饰将细胞信号转化为VSMC表型变化.
结论:
- 染色体重塑是血管重塑中的一个核心机制.
- 向染色体重塑剂为血管疾病提供了一个有希望的治疗策略.
- 需要进一步的研究来探索染色体重塑调制的临床应用.
更多相关视频
09:06Quantitative Analysis of Cellular Composition in Advanced Atherosclerotic Lesions of Smooth Muscle Cell Lineage-Tracing Mice
Published on: February 20, 2019
09:29Assessing Cardiomyocyte Subtypes Following Transcription Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts
Published on: March 22, 2017
相关概念视频
Chromatin Modification in iPS Cells
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
Regulation of Angiogenesis and Blood Supply
Mechanism of Angiogenesis
Nucleosome Remodeling
Nucleosome remodeling complex
Eukaryotic cells have specialized enzymes called ATP-dependent nucleosome remodeling enzymes. These enzymes...
